Dan Lemaitre, former president and CEO of CoreValve Inc., will head up Essex Woodlands Health Ventures' new medical device fund, White Pine Medical, starting out with $50 million.
Lemaitre guided CoreValve, which was acquired by Minneapolis, Minn.-based Medtronic Inc. in April 2009, in negotiations for the sale of the company in a deal worth $700 million in cash, with an additional $150 million payable upon achievement of milestones, according to the fund.
Prior to joining CoreValve, Lemaitre was a senior vice president at Medtronic, where he led strategic planning and corporate development. Previously, hespent 28 years in the medical device field as an investment analyst at SG Cowen and Merrill Lynch.